<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Clinical effectiveness of granulocyte transfusions collected by filtration or by intermittent flow centrifugation was compared in this study </plain></SENT>
<SENT sid="1" pm="."><plain>In 251 patients receiving at least four daily transfusions of these products, there was no difference in response rate (67% in each group) as determined by defervescence </plain></SENT>
<SENT sid="2" pm="."><plain>The most important factor in the recovery of patients appeared to be the underlying disease causing the <z:mp ids='MP_0000334'>agranulocytosis</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>Patients whose marrows were temporarily suppressed by chemotherapy showed the highest recovery rates (82% <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and <z:mp ids='MP_0002038'>carcinoma</z:mp>), whereas those with intrinsic disease in the marrow showed the lowest recovery rates (47% <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo>, 63% <z:hpo ids='HP_0002488'>acute leukemia</z:hpo>) </plain></SENT>
</text></document>